|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.83% |
|
0.00% | +20.00% |
| Mar. 22 | Fourth Amended Joint Reorganization Plan Approved for Endo International plc | CI |
| Mar. 20 | Health Care Down on Rate Bias -- Health Care Roundup | DJ |
WASHINGTON, Jan 25 (Reuters) - The U.S. Federal Trade Commission said on Monday it is filing a lawsuit against Endo Pharmaceuticals and Impax Laboratories which alleges a 2017 agreement eliminated competition between them for oxymorphone ER.
The FTC has previously filed a lawsuit against the two companies regarding the same drug, it said. (Reporting by Diane Bartz Editing by Chris Reese)
| 1st Jan change | Capi. | |
|---|---|---|
| +20.00% | 141K | |
| +115.83% | 4.88B | |
| +1.70% | 1.01B | |
| +2.38% | 982M | |
| +41.91% | 872M | |
| +25.67% | 836M | |
| +1.72% | 663M | |
| +1.80% | 610M | |
| -.--% | 600M | |
| +23.11% | 578M |
ENDO INTERNATIONAL PLC 
